Overview

Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The study will estimate the effects of rolofylline, alone and in addition to loop diuretic therapy on pulmonary capillary wedge pressure and other hemodynamic parameters, in patients with heart failure and renal impairment.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
NovaCardia, Inc.
Treatments:
Rolofylline